Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2022 and 2023.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2023
PK PHARMA CONSULT from Villers-le-Bouillet, company number BE0750549277, closed financial year 2023 with a result of € -11,965 after tax. For that financial year PK PHARMA CONSULT recorded a gross margin of € -10,628 and equity of € 29,516. Compared with financial year 2022, the result moved from € -4,754 to € -11,965. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2024.
€ 29,516
▼ 30% vs 2022
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -11,965
▼ 152 % more loss than in 2022
Profit after tax over the fiscal year.
€ 14,256
▲ 22% vs 2022
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 27,016.
People and assets in 2023
€ 739
▼ 34% vs 2022
Book value of vehicles, furniture and equipment.
Debts at end 2023
None
No bank loans on the last day of the fiscal year.
€ 191
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | Change 2022 → 2023 | |
|---|---|---|---|---|
| Gross margin | € 72,549 | € -3,659 | € -10,628 | ▼ € 6,969 |
| Profit after taxes | € 44,568 | € -4,754 | € -11,965 | ▼ € 7,211 |
| Equity | € 47,068 | € 42,314 | € 29,516 | ▼ 30% |
| Total debts | € 17,212 | € 800 | € 191 | ▼ 76% |
| Cash | € 25,707 | € 11,653 | € 14,256 | ▲ 22% |
| Retained profit | € 44,568 | € 39,814 | € 27,016 | ▼ 32% |
| Dividend | € 0 | € 0 | € 833 | |
| Balance sheet total | € 64,280 | € 43,114 | € 29,707 | ▼ 31% |
Key figures of PK PHARMA CONSULT, fiscal years 2021 to 2023, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2024 has not been filed yet; it was expected before 31 July 2025.
What happened to PK PHARMA CONSULT?
What happened at PK PHARMA CONSULT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
PK PHARMA CONSULT is active according to the CBE. Legal situation: Opening faillissement.
- New annual accounts for financial year 2023: loss of € 11,965. Source: NBB ↗
- New establishment in Villers-le-Bouillet. KBO
- Start of the company according to the CBE. KBO
In short
From € 44,568 profit in 2021 to € 11,965 loss in 2023.
Paid € 14,000 in corporate taxes since 2021.
Best year ever: 2021, with € 44,568 profit.
Paid out € 833 in dividends to the owners in total.
A new publication or filing at PK PHARMA CONSULT? We notify you, reason included.
Follow PK PHARMA CONSULTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Rue de Huy 88
4530 Villers-le-Bouillet
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0750.549.277
- VAT number
- BE 0750.549.277
- Registered office
- Rue de Huy 88, 4530 Villers-le-Bouillet
- Names & denominations
- PK PHARMA CONSULT
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Opening faillissement
- Start date
- 10 July 2020
- Peppol
- Not registered
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering